Moleculary Confirmed, Cytogenetic Remission in a Case with Myelodysplastic Syndrome Treated with Azacitidne
Authors
Irina Panovska-Stavridis
University Clinic of Hematology, UKIM – Faculty of Medicine, Skopje
Martin Ivanovski
University Clinic of Hematology, UKIM – Faculty of Medicine, Skopje
Sanja Trajkova
University Clinic of Hematology, UKIM – Faculty of Medicine, Skopje
Aleksandra Pivkova-Veljanovska
University Clinic of Hematology, UKIM – Faculty of Medicine, Skopje
Marija Popova-Labaceska
University Clinic of Hematology, UKIM – Faculty of Medicine, Skopje
Nadica Matevska-Geshovska
Center of Biomolecular Pharmaceutical Analyses, UKIM - Faculty of Pharmacy, Skopje
Predrag Noveski
Research Centre for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Academy of Sciences and Arts, Skopje
Dijana Plaseska-Karanfilska
Research Centre for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Academy of Sciences and Arts, Skopje
Lidija Cevreska
University Clinic of Hematology, UKIM – Faculty of Medicine, Skopje
Aleksandar J. Dimovski
Center of Biomolecular Pharmaceutical Analyses, UKIM - Faculty of Pharmacy, Skopje
Language: English
Page range: 157 - 162
Published on: Apr 16, 2018
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Related subjects:
© 2018 Irina Panovska-Stavridis, Martin Ivanovski, Sanja Trajkova, Aleksandra Pivkova-Veljanovska, Marija Popova-Labaceska, Nadica Matevska-Geshovska, Predrag Noveski, Dijana Plaseska-Karanfilska, Lidija Cevreska, Aleksandar J. Dimovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.